Darron Segall
About Darron Segall
Darron Segall serves as the Sr. Director of Market Access & Billing at Sera Prognostics, where he has worked since 2021. He has extensive experience in health economics and market access, having held various leadership roles in the healthcare industry since the early 2000s.
Work at Sera Prognostics
Darron Segall currently serves as the Senior Director of Market Access & Billing at Sera Prognostics, a role he has held since 2021. In this position, he focuses on developing value-based commercialization strategies that facilitate rapid market adoption of clinical diagnostic tests. Prior to this role, he was the Senior Director of Market Access at the same company from 2020 to 2021, where he contributed to the organization's market access initiatives.
Previous Experience in Health Economics
Before joining Sera Prognostics, Darron Segall held various positions in health economics and reimbursement. He worked at Quidel Corporation as the Associate Director of Reimbursement and Health Economics from 2005 to 2011. He also served as the Director of Health Economics & Outcomes Research at Verinata Health, Inc. from 2011 to 2013. Additionally, he was the Senior Director of Commercial Operations at NantOmics, LLC from 2015 to 2016, and the Director of Health Economics, Reimbursement & Managed Care at Rapid Pathogen Screening, Inc. from 2013 to 2014.
Education and Expertise
Darron Segall earned a Master of Health Sciences from The Johns Hopkins Bloomberg School of Public Health, specializing in Health Finance & Management and Health Policy & Management, from 1994 to 1996. He also holds a Bachelor of Arts degree in Sociology and Pre-Med from the University of California, Los Angeles, which he completed from 1989 to 1994. His educational background supports his expertise in health economics and market access strategies.
Entrepreneurial Ventures
In addition to his corporate roles, Darron Segall co-founded DiagnoEconomics, Inc., where he worked from 2018 to 2020. This venture focused on health economics and market access, contributing to his extensive experience in the field. His entrepreneurial efforts complement his work in established organizations, showcasing his commitment to advancing health economics.